Heron Therapeutics, Inc. (HRTX): Shares Outstanding
188.31M
As of 2025-12-31
+16.5%
3-year compound annual growth
+15.6%
5-year compound annual growth
+18.0%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 188.31M | +23.8% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 152.13M | +1.2% | 2026-02-26, Balance as of period end |
| 2023-12-31 | 150.29M | +26.1% | 2025-02-27, Balance as of period end |
| 2022-12-31 | 119.15M | +16.8% | 2024-03-12, Balance as of period end |
| 2021-12-31 | 102.00M | +11.7% | 2023-03-29, Balance as of period end |
| 2020-12-31 | 91.31M | +1.1% | 2022-02-28, Balance as of period end |
| 2019-12-31 | 90.30M | +15.5% | 2021-02-24, Balance as of period end |
| 2018-12-31 | 78.17M | +21.0% | 2020-03-02, Balance as of period end |
| 2017-12-31 | 64.61M | n/m | 2019-02-22, Balance as of period end |
| 2016-12-31 | 39.4K | -99.9% | 2018-02-27, Balance as of period end |
| 2015-12-31 | 36.11M | +23.5% | 2017-02-23, Balance as of period end |
| 2014-12-31 | 29.23M | +24.0% | 2016-02-19, Balance as of period end |
| 2013-12-31 | 23.57M | n/c | 2015-03-13, Balance as of period end |
| 2012-12-31 | 15.11M | -92.4% | 2014-03-07, Balance as of period end |
| 2011-12-31 | 200.05M | n/c | 2013-03-01, Balance as of period end |
| 2010-12-31 | 40.14M | n/a | 2012-03-26, Balance as of period end |